The reverse split is a mechanical event that does not change the company's fundamental value or cash position. However, it signals that AEMD is at risk of Nasdaq delisting due to its low stock price. Monitor for any subsequent equity offering (common in post-split micro-caps) and for the next quarterly filing to assess operating cash burn and going-concern risk.
Price Chart
Executive Summary
Aethlon Medical filed a Certificate of Change to effect a 1-for-5 reverse stock split, effective July 31, 2026, to regain compliance with Nasdaq's minimum bid price rule (Listing Rule 5550(a)(2)). The split reduces outstanding shares from ~3.25 million to ~649,914 and authorized shares from 100 million to 20 million. This is a routine capital structure adjustment for a micro-cap company facing delisting, with no change to proportional ownership or fundamental value.
Key Facts
- 1-for-5 reverse stock split effective July 31, 2026; trading on split-adjusted basis expected August 4, 2026.
- Outstanding shares reduced from 3,249,569 to approximately 649,914.
- Authorized shares reduced from 100,000,000 to 20,000,000.
- Split is explicitly intended for continued compliance with Nasdaq Listing Rule 5550(a)(2) (minimum bid price).
- No stockholder approval required under Nevada law.
- Market cap is approximately $1M, with 0% analyst bullish consensus.
Financial Impact
No direct financial impact; reverse split is a mechanical share consolidation. The company's market cap remains ~$1M. The split is a delisting-avoidance measure, not a value-creating event.
Risk Factors
- Post-split stock price may still fail to maintain Nasdaq's $1.00 minimum bid price, leading to delisting.
- Reverse splits in micro-cap companies are often followed by dilutive equity offerings, further pressuring the stock.
- Extremely low market cap ($1M) and negative analyst sentiment (0% bullish) indicate high risk of shareholder value erosion.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (AEMD) — Batch item 1 | 0001683168-26-005850 |
| Document: aethlon_ex0301.htm | 0001683168-26-005850 |
| Document: 0001683168-26-005850-index-headers.html | 0001683168-26-005850 |
| Document: 0001683168-26-005850-index.html | 0001683168-26-005850 |
| Document: 0001683168-26-005850.txt | 0001683168-26-005850 |
| 8-K Filing (AEMD) — Batch item 6 | 0001683168-26-005850 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | SC 13G | $5.05 $5.07 | ▲ +0.40% | ▼ −0.06% | $5.07 (+0.40%) |
Oct 1, 2026 25d ago | 8-K | $6.45 $6.05 | ▲ +6.20% | ▲ +7.36% | $5.07 (+21.40%) |
Sep 17, 2026 5w ago | 425 | $6.78 $6.77 | ▼ −0.15% | ▼ −0.75% | $5.07 (−25.22%) |
Sep 17, 2026 5w ago | 8-K | $6.78 $6.77 | ▼ −0.15% | ▼ −0.75% | $5.07 (−25.22%) |
Sep 15, 2026 6w ago | 8-K | $1.47 $6.31 | ▲ +329.25% | ▲ +328.43% | $5.07 (+244.90%) |
Sep 4, 2026 7w ago | DEFA14A | $1.81 $1.47 | ▲ +18.78% | ▲ +17.67% | $5.07 (−180.11%) |
Aug 31, 2026 8w ago | 8-K | $2.06 $1.81 | ▼ −12.14% | ▼ −11.99% | $5.07 (+146.12%) |
Aug 13, 2026 10w ago | Press Release | $2.83 $2.73 | ▼ −3.53% | ▼ −2.17% | $5.07 (+79.15%) |
Jul 31, 2026 12w ago | 8-K | $0.6628 $0.6300 | ▲ +4.95% | ▲ +8.46% | $5.07 (−664.94%) |
Jul 7, 2026 16w ago | EFFECT | $0.7297 $0.6850 | ▲ +6.13% | ▲ +6.68% | $5.07 (−594.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers